Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Moretti

Showing results (341-350 of 359) with videos related to

Pageof 36
Sort By:
Ejhaem|November 29, 2023
FLT3-targeted therapy restores GATA1 pathway function in NPM1/FLT3-ITD mutated acute myeloid leukaemiaD Sorcini, A Stella, A Scialdone, et al.
Physics in Medicine and Biology|July 5, 2011
Comparison of manual and automatic segmentation methods for brain structures in the presence of space-occupying lesions: a multi-expert studyM A Deeley, A Chen, R Datteri, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 16, 2000
Randomized trial of fludarabine versus fludarabine and idarubicin as frontline treatment in patients with indolent or mantle-cell lymphomaP L Zinzani, M Magagnoli, L Moretti, et al.
Annali Di Igiene : Medicina Preventiva E Di Comunita|July 21, 2022
Impact of Covid-19 pandemic on injection-based practice: report from an Italian multicenter and multidisciplinary surveyS Tenti, N Mondanelli, A Bernetti, et al.
Blood|July 29, 1998
Anaplastic large cell lymphoma Hodgkin's-like: a randomized trial of ABVD versus MACOP-B with and without radiation therapyP L Zinzani, M Martelli, M Magagnoli, et al.
Scientific Reports|September 20, 2022
Low skeletal muscle radiodensity and neutrophil-to-lymphocyte ratio as predictors of poor outcome in patients with COVID-19Daniela M H Padilha, Maria C S Mendes, Fabiana Lascala, et al.
Blood|June 25, 1999
Elderly aggressive-histology non-Hodgkin's lymphoma: first-line VNCOP-B regimen experience on 350 patientsP L Zinzani, S Storti, A Zaccaria, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 28, 2002
Randomized trial of 8-week versus 12-week VNCOP-B plus G-CSF regimens as front-line treatment in elderly aggressive non-Hodgkin's lymphoma patientsP L Zinzani, F Gherlinzoni, S Storti, et al.
ESMO Gastrointestinal Oncology|February 6, 2026
Efficacy and safety of short-course radiotherapy versus total neoadjuvant therapy in older rectal cancer patients: a randomised pragmatic trial (SHAPERS)R Saúde-Conde, T Vandamme, M De Backer, et al.
Experimental Biology and Medicine (Maywood, N.J.)|July 19, 2021
Identification of SARS-CoV-2 on the ocular surface in a cohort of COVID-19 patients from BrazilMatheus S Gasparini, Leandro M Dos Santos, Ahmad Ma Hamade, et al.
Pageof 36

Showing results (341-350 of 359) with videos related to

Sort By:
Pageof 36
Ejhaem|November 29, 2023
FLT3-targeted therapy restores GATA1 pathway function in NPM1/FLT3-ITD mutated acute myeloid leukaemiaD Sorcini, A Stella, A Scialdone, et al.
Physics in Medicine and Biology|July 5, 2011
Comparison of manual and automatic segmentation methods for brain structures in the presence of space-occupying lesions: a multi-expert studyM A Deeley, A Chen, R Datteri, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 16, 2000
Randomized trial of fludarabine versus fludarabine and idarubicin as frontline treatment in patients with indolent or mantle-cell lymphomaP L Zinzani, M Magagnoli, L Moretti, et al.
Annali Di Igiene : Medicina Preventiva E Di Comunita|July 21, 2022
Impact of Covid-19 pandemic on injection-based practice: report from an Italian multicenter and multidisciplinary surveyS Tenti, N Mondanelli, A Bernetti, et al.
Blood|July 29, 1998
Anaplastic large cell lymphoma Hodgkin's-like: a randomized trial of ABVD versus MACOP-B with and without radiation therapyP L Zinzani, M Martelli, M Magagnoli, et al.
Scientific Reports|September 20, 2022
Low skeletal muscle radiodensity and neutrophil-to-lymphocyte ratio as predictors of poor outcome in patients with COVID-19Daniela M H Padilha, Maria C S Mendes, Fabiana Lascala, et al.
Blood|June 25, 1999
Elderly aggressive-histology non-Hodgkin's lymphoma: first-line VNCOP-B regimen experience on 350 patientsP L Zinzani, S Storti, A Zaccaria, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 28, 2002
Randomized trial of 8-week versus 12-week VNCOP-B plus G-CSF regimens as front-line treatment in elderly aggressive non-Hodgkin's lymphoma patientsP L Zinzani, F Gherlinzoni, S Storti, et al.
ESMO Gastrointestinal Oncology|February 6, 2026
Efficacy and safety of short-course radiotherapy versus total neoadjuvant therapy in older rectal cancer patients: a randomised pragmatic trial (SHAPERS)R Saúde-Conde, T Vandamme, M De Backer, et al.
Experimental Biology and Medicine (Maywood, N.J.)|July 19, 2021
Identification of SARS-CoV-2 on the ocular surface in a cohort of COVID-19 patients from BrazilMatheus S Gasparini, Leandro M Dos Santos, Ahmad Ma Hamade, et al.
Pageof 36